Managing experts’ conflicts of interest in the EU Joint Clinical Assessment
Arianna Gentilini, Iva Parvanova · 2024
Read Managing experts’ conflicts of interest in the EU Joint Clinical Assessment by Arianna Gentilini, Iva Parvanova (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11574398.txt.
Description
Arianna Gentilini and Iva Parvanova review in 2024 how the European Union handles conflicts of interest in its new joint drug assessments. Under the scheme, experts such as clinicians and patient advocates help judge new medicines for all member states at once. A 2024 regulation sets the first EU-wide rules for declaring and managing their financial and non-financial ties.
The authors compare the rules with national approaches and find them closely modeled on French practice. Gaps include silence on organizational conflicts, fuzzy rules on how much money counts, and possible skew toward experts from few countries. Enforcement funding is also unclear, they warn, risking uneven compliance.
Catalog record
| CREATOR | Arianna Gentilini, Iva Parvanova |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |